48,830
edits
Line 111: | Line 111: | ||
===Mesothelium=== | ===Mesothelium=== | ||
*Calretinin. | Panel:<ref name=pmid18318582>{{cite journal |author=Marchevsky AM |title=Application of immunohistochemistry to the diagnosis of malignant mesothelioma |journal=Arch. Pathol. Lab. Med. |volume=132 |issue=3 |pages=397-401 |year=2008 |month=March |pmid=18318582 |doi= |url=http://journals.allenpress.com/jrnlserv/?request=get-abstract&issn=0003-9985&volume=132&page=397}}</ref> | ||
*WT-1. | *Mesothelial markers: | ||
*D2-40. | **Calretinin. | ||
*CK5/6. | **WT-1. | ||
**D2-40. | |||
**CK5/6. | |||
*Carcinoma markers: | |||
**CEA (monoclonal and polyclonal). | |||
**TTF-1. | |||
**Ber-EP4. | |||
**MOC-31. | |||
Note: | |||
* | *One should use two mesothelial markers ''and'' two carcinoma markers.<ref name=pmid18318582/> | ||
===[[Pancreas]]=== | ===[[Pancreas]]=== |
edits